Array Technologies, Inc. Reports Financial Results for the First Quarter 2022 – Delivers strong top-line growth, a robust backlog and continued margin progression in the legacy Array business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.30 -0.11 (3.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.41 | 52 Week High | $7.27 | |||
| Open | $3.29 | 52 Week Low | $2.39 | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $-0.61 | |||
| Volume | 6,843,059 | |||||
